Dr. Upadhyaya is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 E. Medical Center Drive
Ann Arbor, MI 48109
Summary
- Dr. Santhosh Upadhyaya, MD, is a Pediatric Hematology and Oncology specialist with subspeciality in Pediatric Neuro-Oncology based in Ann Arbor, Michigan, USA. His education includes fellowships in both Pediatric Hematology/Oncology and Pediatric Neuro-Oncology from University of Michigan Health System and St. Jude Children's Research Hospital, Memphis, Tennessee, respectively. He completed his residency at Kasturba Medical College, Manipal, India and Ascension St John Hospital, Michigan, USA and graduated from Kasturba Medical College Mangalore, India. Currently, he is an Associate Professor at C. S. Mott Children's Hospital, he has previously held the position of Assistant Professor at St. Jude Children's Research Hospital. Dr. Upadhyaya has multiple published papers in renowned journals, some of which have been highly cited. His clinical trial involvement includes work on ependymoma and ATRT
Education & Training
- University of TennesseeFellowship, Pediatric Neuro-Oncology, 2015 - 2016
- University of MichiganFellowship, Pediatric Hematology/Oncology, 2012 - 2015
- Ascension St John HospitalResidency, Pediatrics, 2009 - 2012
- Kasturba Medical College ManipalClass of 2000
Certifications & Licensure![](https://directory.doximity.com/assets/icons/icon-help-e9f0b148a1e6d1f037dde9f26f025c36bd7c99fd4fe31fd76792996fa2aa5e66.svg)
- MI State Medical License 2012 - 2025
- TN State Medical License 2016 - 2024
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
Publications & Presentations
PubMed
- Outcomes for children with recurrent/refractory atypical teratoid rhabdoid tumor: A single-institution study with molecular correlation.Steven S Carey, Jie Huang, Jason R Myers, Roya Mostafavi, Brent A Orr
Pediatric Blood & Cancer. 2024-10-01 - Long-Term Tumor Stability After First-Line Treatment With Larotrectinib in an Infant With NTRK2 Fusion-Positive High-Grade Glioma.Jillian Simoneau, Patricia Robertson, Karin Muraszko, Cormac O Maher, Hugh Garton
Journal of the National Comprehensive Cancer Network. 2024-09-01 - Atypical teratoid/rhabdoid tumour-TYR subtype arising in the setting of germline ring chromosome 22: An uncommon form of tumour predisposition.Julieann C Lee, Quynh T Tran, Rose B McGee, Melissa R Perrino, Santhosh A Upadhyaya
Neuropathology and Applied Neurobiology. 2024-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: